Applications
3D Printing is Helping Doctors to Treat Lupus
Once again, doctors are turning to 3D printing to solve unique issues in the field of medicine. In this case, engineers and doctors at the University of Minnesota Twin Cities used the technology to develop a unique light-sensing medical device…
- 3 min read
- Applications
- Six more stories

Once again, doctors are turning to 3D printing to solve unique issues in the field of medicine. In this case, engineers and doctors at the University of Minnesota Twin Cities used the technology to develop a unique light-sensing medical device which can be used in the treatment of Lupus, an often debilitating autoimmune disorder. By placing it directly on the skin, the device will enable real-time feedback to correlate light exposure with disease flare-ups. It is expected to help doctors to provide more personalized treatments and information.
Lupus is an autoimmune disorder, meaning that it causes the body’s immune system to attack its own tissues and organs. According to Mayo Clinic, the resulting inflammation can impact various body systems including joints, skin, kidneys, blood cells, brain heart and lungs. Lupus is not only difficult to diagnose but tricky to treat, notably because no two cases will be exactly the same. Considering that the Lupus Foundation of America estimates that 1.5 million Americans and at least 5 million people worldwide have a form of the disease, finding ways to help is critical.

Initial results from the tests have been promising (photo credits: University of Minnesota)
The researchers used 3D printing to create customized devices which in turn can be used for personalized treatments for patients with Lupus. Given the fact that the disease is known to provoke light sensitivity and worsen with exposure to UV exposure (both through sunlight and artificial lights), the authors sought to create a device that could track the correlation of light to symptoms of the disorder. Dr. David Pearson, a University of Michigan Medical School dermatologist and co-author of the study, explained the importance of this type of research, commenting, “I treat a lot of patients with lupus or related diseases, and clinically, it is challenging to predict when patients’ symptoms are going to flare. We know that ultraviolet light and, in some cases visible light, can cause flares of symptoms—both on their skin, as well as internally—but we don’t always know what combinations of light wavelengths are contributing to the symptoms.”





